Tsang V, Gill A, Gild M, Lurie B, et al. Selpercatinib treatment of RET mutated thyroid cancers is associated with gastrointestinal adverse effects. J Clin Endocrinol Metab 2022 Jun 1. pii: 6596759. doi: 10.1210.
PMID: 35647935